Ho-Juhn Song is the Founder and CEO of PineTree Therapeutics, a biotech company developing multi-functional antibody therapies for hard-to-treat cancers. With deep experience in drug discovery and development, he has helped bring multiple drug candidates into clinical trials. Before founding PineTree, Ho-Juhn led research projects at Novartis, focusing on neuroscience and genetic disease models. He holds a Ph.D. in Genetics and Neurosciences from Oregon State University.